1. Genetics of Alzheimer’s Disease and Research Models
    Sapeck Agrawal, 2017, MATER METHODS CrossRef
  2. Age- and Brain Region-Specific Changes of Glucose Metabolic Disorder, Learning, and Memory Dysfunction in Early Alzheimer’s Disease Assessed in APP/PS1 Transgenic Mice Using 18F-FDG-PET
    Xue-Yuan Li et al, 2016, IJMS CrossRef
  3. Human Neural Stem Cell Transplantation Rescues Cognitive Defects in APP/PS1 Model of Alzheimer’s Disease by Enhancing Neuronal Connectivity and Metabolic Activity
    Xueyuan Li et al, 2016, Front. Aging Neurosci. CrossRef
  4. Neurogenesis-based epigenetic therapeutics for Alzheimer's disease (Review)
    Xueyuan Li et al, 2016 CrossRef
  5. Microglia-targeted stem cell therapies for Alzheimer disease: A preclinical data review
    Zhiwei Shen et al, 2017, Journal of Neuroscience Research CrossRef
  6. Galangin’s potential as a functional food ingredient
    Kit-Kay Mak et al, 2018, Journal of Functional Foods CrossRef
  7. Multifaceted Assessment of the APP/PS1 Mouse Model for Alzheimer’s disease: Applying MRS, DTI, and ASL
    Zhiwei Shen et al, 2018, Brain Research CrossRef
  8. Clinical PET Imaging of Microglial Activation: Implications for Microglial Therapeutics in Alzheimer’s Disease
    Zhiwei Shen et al, 2018, Front. Aging Neurosci. CrossRef
  9. Age dependent behavioral and biochemical characterization of single APP knock-in mouse (APPNL-G-F/NL-G-F) model of Alzheimer's disease
    Jogender Mehla et al, 2018, Neurobiology of Aging CrossRef
  10. Alzheimer’s Disease: Animal Research Models
    Sapeck Agrawal, 2017, MATER METHODS CrossRef
  11. Effect of Chinese herbal compound GAPT on the early brain glucose metabolism of APP/PS1 transgenic mice
    Lulu Mana et al, 2019, Int J Immunopathol Pharmacol CrossRef
  12. Development and validation of Alzheimer’s Disease Animal Model for the Purpose of Regenerative Medicine
    Parisa Goodarzi et al, 2019, Cell Tissue Bank CrossRef
  13. The mitochondria-targeted antioxidant MitoQ inhibits memory loss, neuropathology, and extends lifespan in aged 3xTg-AD mice
    Melissa L. Young et al, 2019, Molecular and Cellular Neuroscience CrossRef
  14. Age‑ and brain region‑associated alterations of cerebral blood flow in early Alzheimer's disease assessed in AβPPSWE/PS1ΔE9 transgenic mice using arterial spin labeling
    Yapei Guo et al, 2019, Mol Med Report CrossRef
  15. Critical Review of the Alzheimer’s Disease Non-Transgenic Models: Can They Contribute to Disease Treatment?
    Julio A. Flores-Cuadra et al, 2020, JAD CrossRef
  16. Patient-derived iPSCs, a reliable in vitro model for the investigation of Alzheimer’s disease
    Asiamah Ernest Amponsah et al, 2021 CrossRef
  17. Brain energy metabolism in intracerebroventricularly administered streptozotocin mouse model of Alzheimer’s disease: A 1H-[13C]-NMR study
    Narayan D Soni et al, 2021, J Cereb Blood Flow Metab CrossRef
  18. The Protective Effects of Trans-Cinnamaldehyde against D-Galactose and Aluminum Chloride-Induced Cognitive Dysfunction in Mice
    null Jong-Sik Ryu et al, 2021, Neurochem. J. CrossRef
  19. Potential ameliorative effect of Cynodon dactylon (L.) pers on scopolamine-induced amnesia in rats: Restoration of cholinergic and antioxidant pathways
    LaxmiA Pattanashetti et al, 2021, Indian J Pharmacol CrossRef
  20. null
    Richard Young, 2021 CrossRef
  21. Extracellular GAPDH Promotes Alzheimer Disease Progression by Enhancing Amyloid-β Aggregation and Cytotoxicity
    Vladimir F Lazarev et al, 2021, Aging and disease CrossRef
  22. WIN55,212-2 Attenuates Cognitive Impairments in AlCl3 + d-Galactose-Induced Alzheimer’s Disease Rats by Enhancing Neurogenesis and Reversing Oxidative Stress
    Onesimus Mahdi et al, 2021, Biomedicines CrossRef
  23. Proton Stimulation Targeting Plaque Magnetite Reduces Amyloid-β Plaque and Iron Redox Toxicity and Improves Memory in an Alzheimer’s Disease Mouse Model
    Seung-Jun Seo et al, 2021, JAD CrossRef
  24. Microfluidic Platforms to Unravel Mysteries of Alzheimer’s Disease: How Far Have We Come?
    Pragya Prasanna et al, 2021, Life CrossRef
  25. Effects of Aminoguanidine on Apoptosis in the Hippocampus and Memory Disorder in a Rat Model of Alzheimer’s Disease
    Hamid Reza Sameni et al, 2021, Middle East J Rehabil Health Stud CrossRef
  26. Naproxen as a potential candidate for promoting rivastigmine anti-Alzheimer activity against aluminum chloride-prompted Alzheimer's-like disease in rats; neurogenesis and apoptosis modulation as a possible underlying mechanism
    Raafat A. Abdel-Aal et al, 2022, European Journal of Pharmacology CrossRef
  27. Amyloid-β oligomers in the nucleus accumbens decrease motivation via insertion of calcium-permeable AMPA receptors
    Changyong Guo et al, 2022, Mol Psychiatry CrossRef
  28. Experimental modelling of Alzheimer’s disease for therapeutic screening
    Laura Blaikie et al, 2022, European Journal of Medicinal Chemistry Reports CrossRef
  29. Amyloid‐β Inspired Short Peptide Amphiphile Facilitates Synthesis of Silver Nanoparticles as Potential Antibacterial Agents
    Satyendra K. Tripathi et al, 2022, ChemMedChem CrossRef
  30. The Path to Progress Preclinical Studies of Age-Related Neurodegenerative Diseases: A Perspective on Rodent and hiPSC-Derived Models
    Gabriella MacDougall et al, 2021, Molecular Therapy CrossRef
  31. Fiscalin Derivatives as Potential Neuroprotective Agents
    Sandra Barreiro et al, 2022, Pharmaceutics CrossRef
  32. Amelioration of intracerebroventricular streptozotocin-induced cognitive dysfunction by Ocimum sanctum L. through the modulation of inflammation and GLP-1 levels
    Bansy Patel et al, 2022, Metab Brain Dis CrossRef
  33. The age-specific pathological changes of β-amyloid plaques in the cortex and hippocampus of APP/PS1 transgenic AD mice
    Lu-Lu Xue et al, 2022, Neurological Research CrossRef
  34. Features of the Development and Analysis of Impairments to Social Behavior and Cognitive Functions in Animals with Experimental Alzheimer’s Disease
    Ya. V. Gorina et al, 2022, Neurosci Behav Physi CrossRef
  35. Fats, Friends or Foes: Investigating the Role of Short- and Medium-Chain Fatty Acids in Alzheimer’s Disease
    Aishat O. Ameen et al, 2022, Biomedicines CrossRef
  36. Phytochemical based Modulation of Endoplasmic Reticulum Stress in Alzheimer's Disease
    Venzil Lavie Dsouza et al, 2022, CTMC CrossRef
  37. Verbenalin Reduces Amyloid-Beta Peptide Generation in Cellular and Animal Models of Alzheimer’s Disease
    Juhee Lim et al, 2022, Molecules CrossRef
  38. Preclinical Models for Alzheimer’s Disease: Past, Present, and Future Approaches
    Ansab Akhtar et al, 2022, ACS Omega CrossRef
  39. 8- Hydroxyquinolylnitrones as multifunctional ligands for the therapy of neurodegenerative diseases
    Damijan Knez et al, 2023, Acta Pharmaceutica Sinica B CrossRef
  40. Inhibition of protease-activated receptor 1 (PAR1) ameliorates cognitive performance and synaptic plasticity impairments in animal model of Alzheimer's diseases.
    Daruoosh Zare et al, 2021, Psychopharmacology (Berl) CrossRef
  41. Thymol in Trachyspermum ammi seed extract exhibits neuroprotection, learning, and memory enhancement in scopolamine‐induced Alzheimer's disease mouse model
    Binod Timalsina et al, 2023, Phytotherapy Research CrossRef
  42. Effects of Phytochemicals from Fermented Food Sources in Alzheimer’s Disease In Vivo Experimental Models: A Systematic Review
    Alina Mihaela Baciu et al, 2023, Foods CrossRef
  43. Alzheimer Hastalığı’nda In Vivo ve In Vitro Modeller
    Başak ARU et al, 2023 CrossRef
  44. ANIMAL MODELS OF ALZHEIMER’S DISEASE: AN ORIGIN OF INNOVATIVE TREATMENTS AND INSIGHT TO THE DISEASE'S ETIOLOGY
    Ritu S. Chavan et al, 2023, Brain Research CrossRef
  45. Differential roles of regulatory T cells in Alzheimer's disease
    Abdollah Jafarzadeh et al, 2023, Cellular Immunology CrossRef
  46. THE INFLUENCE OF MESENCHYMAL STEM CELLS ON THE DYNAMICS OF REGULATOR OF ENDOTHELIAL PROLIFERATION EXPRESSIONS IN THE BRAIN STRUCTURES OF RATS WITH EXPERIMENTAL ALZHEIMER-TYPE DEMENTIA
    O.O. Pavlova et al, 2023, Act. Probl. of the Modern Med. CrossRef
  47. Preliminary study on early diagnosis of Alzheimer’s disease in APP/PS1 transgenic mice using multimodal magnetic resonance imaging
    Meng Xu et al, 2024, Front. Aging Neurosci. CrossRef
  48. Neuroprotective effects of dendrobium endophytes metabolites in SH-SY5Y cells via the Nrf2/Keap1 pathway
    Yan tian Liang et al, 2024, Heliyon CrossRef
  49. Experimental Animal Models in Neurological Diseases
    Neslihan Şirin et al, 2024, Duzce Med J CrossRef
  50. The role of m6A modification in the risk prediction and Notch1 pathway of Alzheimer’s disease
    Yingdan Qiao et al, 2024, iScience CrossRef